| Year |
Citation |
Score |
| 2020 |
Phenis D, Vunck SA, Valentini V, Arias H, Schwarcz R, Bruno JP. Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task. Psychopharmacology. PMID 32162104 DOI: 10.1007/s00213-020-05495-y |
0.537 |
|
| 2015 |
McClay JL, Vunck SA, Batman AM, Crowley JJ, Vann RE, Beardsley PM, van den Oord EJ. Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 25850894 DOI: 10.1007/S11481-015-9605-1 |
0.742 |
|
| 2015 |
Pershing ML, Bortz DM, Pocivavsek A, Fredericks PJ, Jørgensen CV, Vunck SA, Leuner B, Schwarcz R, Bruno JP. Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia. Neuropharmacology. 90: 33-41. PMID 25446576 DOI: 10.1016/J.Neuropharm.2014.10.017 |
0.685 |
|
| 2013 |
Adkins DE, McClay JL, Vunck SA, Batman AM, Vann RE, Clark SL, Souza RP, Crowley JJ, Sullivan PF, van den Oord EJ, Beardsley PM. Behavioral metabolomics analysis identifies novel neurochemical signatures in methamphetamine sensitization. Genes, Brain, and Behavior. 12: 780-91. PMID 24034544 DOI: 10.1111/Gbb.12081 |
0.717 |
|
| 2013 |
Aberg KA, Xie LY, McClay JL, Nerella S, Vunck S, Snider S, Beardsley PM, van den Oord EJ. Testing two models describing how methylome-wide studies in blood are informative for psychiatric conditions. Epigenomics. 5: 367-77. PMID 23895651 DOI: 10.2217/Epi.13.36 |
0.706 |
|
| 2013 |
McClay JL, Adkins DE, Vunck SA, Batman AM, Vann RE, Clark SL, Beardsley PM, van den Oord EJ. Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure. Metabolomics : Official Journal of the Metabolomic Society. 9: 392-402. PMID 23554582 DOI: 10.1007/S11306-012-0456-Y |
0.729 |
|
| 2012 |
Wiebelhaus JM, Vunck SA, Meltzer HY, Porter JH. Discriminative stimulus properties of N-desmethylclozapine, the major active metabolite of the atypical antipsychotic clozapine, in C57BL/6 mice. Behavioural Pharmacology. 23: 262-70. PMID 22547022 DOI: 10.1097/Fbp.0B013E3283534332 |
0.691 |
|
| 2012 |
Snider SE, Vunck SA, van den Oord EJ, Adkins DE, McClay JL, Beardsley PM. The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice. European Journal of Pharmacology. 679: 75-80. PMID 22306241 DOI: 10.1016/J.Ejphar.2012.01.013 |
0.745 |
|
| 2011 |
Vunck SA, Wiebelhaus JM, Arnt J, Porter JH. Clozapine and N-methyl-D-aspartate have positive modulatory actions on their respective discriminative stimulus properties in C57BL/6 mice. European Journal of Pharmacology. 650: 579-85. PMID 20969851 DOI: 10.1016/J.Ejphar.2010.10.022 |
0.657 |
|
| 2009 |
Philibin SD, Walentiny DM, Vunck SA, Prus AJ, Meltzer HY, Porter JH. Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL/6 mice: role of 5-HT(2A) serotonergic and alpha (1) adrenergic antagonism. Psychopharmacology. 203: 303-15. PMID 18989659 DOI: 10.1007/S00213-008-1385-3 |
0.692 |
|
| 2009 |
Prus AJ, Pehrson AL, Philibin SD, Wood JT, Vunck SA, Porter JH. The role of M1 muscarinic cholinergic receptors in the discriminative stimulus properties of N-desmethylclozapine and the atypical antipsychotic drug clozapine in rats. Psychopharmacology. 203: 295-301. PMID 18685832 DOI: 10.1007/S00213-008-1262-0 |
0.652 |
|
| 2008 |
Porter JH, Walentiny DM, Philibin SD, Vunck SA, Crabbe JC. A comparison of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in DBA/2 and C57BL/6 inbred mice. Behavioural Pharmacology. 19: 530-42. PMID 18690107 DOI: 10.1097/Fbp.0B013E32830Cd84E |
0.767 |
|
| Show low-probability matches. |